For US Healthcare Professionals Only
Ordering Information

Ordering REZZAYO®

Everything you need to know to order REZZAYO® with ease and confidence

REZZAYO® (rezafungin for injection)

200 mg per vial

NDC 70842-240-01
How supplied REZZAYO® (rezafungin for injection) is supplied as a sterile white to pale yellow solid (cake or powder) in a single-dose 20 mL Type I glass vial with a stopper, an aluminum seal, and a blue polypropylene flip-off cap. The vial stopper is not made with natural rubber latex.
Packaging configuration One single-dose vial of REZZAYO® 200 mg
(NDC 70842-240-01)
Storage REZZAYO® vials should be stored at 20°C to 25°C (68°F to 77°F). Brief exposure to 15°C to 30°C (59°F to 86°F) permitted.
How to order REZZAYO® is available through the following distributors.
Practice Type Distributor Phone Web Order Number
Hospitals Cardinal Specialty Pharmaceutical Distribution (CAH SPD) 855-855-0708 pdlogin.cardinalhealth.com 5857990
ASD Healthcare (ABSG) 800-746-6273 www.asdhealthcare.com 10281238
McKesson Plasma and Biologics 877-625-2566 connect.mckesson.com 3034790
Clinics
Infusion centers
Physician offices
Home infusion		 Metro Medical (Cardinal Health) 800-768-2002 www.metromedicalorder.com 202401
Besse Medical 800-543-2111 www.besse.com 10281194
McKesson Plasma and Biologics 877-625-2566 connect.mckesson.com 3034790
McKesson Specialty Health 800-482-6700 mscs.mckesson.com 5020202
Oncology practices Cardinal SPD 877-453-3972 pdlogin.cardinalhealth.com 5857990
Oncology Supply 800-633-7555 www.oncologysupply.com 10281196
McKesson Specialty Health 800-482-6700 mscs.mckesson.com 5020202

Ordering Information

Download Information

Billing and Coding Guide

Download Guide

Explore REZZAYO® patient support resources

Patient Support Resources

INDICATION AND USAGE

REZZAYO® (rezafungin for injection) is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the treatment of candidemia and invasive candidiasis. Approval of this indication is based on limited clinical safety and efficacy data.

Limitations of Use

REZZAYO® has not been studied in patients with endocarditis, osteomyelitis, and meningitis due to Candida.

IMPORTANT SAFETY INFORMATION

Contraindications

REZZAYO® is contraindicated in patients with known hypersensitivity to rezafungin or other echinocandins.

Warnings and Precautions

  • Infusion-related Reactions: REZZAYO® may cause infusion-related reactions, including flushing, sensation of warmth, urticaria, nausea, or chest tightness. If these reactions occur, slow or pause the infusion.
  • Photosensitivity: REZZAYO® may cause photosensitivity. Advise patients to use protection from sun exposure and other sources of UV radiation.
  • Hepatic Adverse Reactions: Abnormalities in liver tests have been seen in clinical trial patients treated with REZZAYO®. Monitor patients who develop abnormal liver tests and evaluate patients for their risk/benefit of continuing REZZAYO® therapy.

Adverse Reactions

Most common adverse reactions (incidence ≥ 5%) are hypokalemia, pyrexia, diarrhea, anemia, vomiting, nausea, hypomagnesemia, abdominal pain, constipation, and hypophosphatemia.

Please see full Prescribing Information for REZZAYO® (rezafungin for injection).

Important Safety Information  

INDICATION AND USAGE

REZZAYO® (rezafungin for injection) is an echinocandin antifungal indicated in patients 18 years of age or older who have limited or no alternative options for the

 

Contraindications

REZZAYO® is contraindicated in patients with known hypersensitivity to rezafungin or other echinocandins.